Parkinson’s Disease Therapeutics Market - Global Industry Analysis

Parkinson’s Disease Therapeutics Market by Drug Class (Levodopa Combination, Dopamine Agonists, Monoamine Oxidase B (MAO-B) Inhibitors, Anticholinergic Drugs, Catechol-O-Methyltransferase (COMT) Inhibitors, and Others), by Route of Administration (Oral, Transdermal, Subcutaneous, and Intestinal Infusion), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 31-May-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2858 Status : Published

Global Parkinson’s disease therapeutics market expected to generate around USD 5.28 billion by 2025, at a CAGR of around 10.6% between 2019 and 2025. Parkinson’s disease (PD) is a nervous system disorder that increases in severity with time. The disease is characterized by its bradykinesia, rigidity, tremor, and postural instability.

Request a Free Sample of Parkinson’s Disease Therapeutics Market

Your personal details are safe and secured with us. Privacy Policy SSL site seal - click to verify

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social